Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.

CSE:RVV - Post by User

Revive Therapeutics Ltd. > Interesting read .. Sionogi's Antiviral Covid Pill

<< Previous

Bullboard Posts

Next >>

Comment by 1ottrunneron Feb 10, 2022 8:35am

43 Views

Post# 34415764

RE:Interesting read .. Sionogi's Antiviral Covid Pill

The comments on this reddit thread are moronic.
First, Japan has had access to Bucillamine for arthritis for 30 years.So the data exists, if you are taking Buc for that indication have you not been hospitalized for Covid.

ding ding ding....that isn't happening!

Second, the more drugs approved for covid treatment the LESS likely RVV is to get approval. The bar is raised every time a new drug is approved.